Medicine and Dentistry
Myositis
100%
COVID-19 Vaccination
54%
Autoimmune Disease
49%
COVID-19
33%
Diseases
31%
Inclusion Body Myositis
24%
Infection
22%
Myopathy
20%
Autoimmune Rheumatic Disease
18%
Adverse Event
17%
Autoantibodies
14%
Disease Activity
13%
Severe Acute Respiratory Syndrome Coronavirus 2
12%
Diagnosis
11%
Patient-Reported Outcome
11%
Inflammatory Disorder
10%
Cross Sectional Study
9%
Neurologic Disease
9%
Skeletal Muscle
9%
Symptom
8%
Outcome Assessment
8%
Systemic Lupus Erythematosus
8%
Systemic Autoimmune Disease
8%
COVID-19 Vaccine
8%
Rheumatic Disease
8%
Vaccine
7%
Systemic Scleroderma
7%
Spinal Muscular Atrophy
7%
Antisynthetase Syndrome
6%
Magnetic Resonance Imaging
6%
Vaccine Hesitancy
6%
Neuropathy
6%
Weakness
6%
Dermatomyositis
6%
Voltage-Gated Potassium Channel
6%
Immunosuppressive Treatment
6%
Polymyositis
5%
Neurological Complication
5%
Muscle Weakness
5%
Myasthenia gravis
5%
Diagnostic Error
5%
Pharmacology, Toxicology and Pharmaceutical Science
Vaccination Policy
65%
Autoimmune Disease
65%
Myositis
62%
Adverse Event
35%
Disease
21%
Infection
15%
Vaccine
15%
Rheumatic Disease
12%
COVID-19 Vaccine
11%
Systemic Lupus Erythematosus
11%
SARS Coronavirus
11%
Disease Activity
10%
Myasthenia gravis
7%
Coronavirinae
7%
Inclusion Body Myositis
7%
Troponin I
6%
Glucocorticoid
5%
Immunology and Microbiology
Myositis
59%
COVID-19
42%
Autoimmune Disease
31%
Vaccination Policy
31%
Autoantibodies
23%
Inclusion Body Myositis
16%
Vaccine Efficacy
16%
Autoimmune Rheumatic Disease
16%
Dermatomyositis
9%
Systemic Lupus Erythematosus
8%
Antisynthetase Syndrome
8%
Systemic Scleroderma
7%
Inflammatory Arthritis
7%
Immunosuppression
7%
Inflammatory Disorder
6%
Polymyositis
6%
Intravenous Immunoglobulin
5%
Monospecific Antibody
5%
